Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NFIL3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA578077
Description
Positive Control: HepG2, HepG2 nuclear extract Predicted Reactivity: Rat (80%), Chicken (89%), Sheep (87%), Rhesus Monkey (98%), Bovine (87%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Expression of interleukin-3 (IL3; MIM 147740) is restricted to activated T cells, natural killer (NK) cells, and mast cell lines. Transcription initiation depends on the activating capacity of specific protein factors, such as NFIL3, that bind to regulatory regions of the gene, usually upstream of the transcription start site (Zhang et al., 1995 [PubMed 7565758]).
Specifications
NFIL3 | |
Polyclonal | |
Unconjugated | |
NFIL3 | |
AV225605; E4 promoter binding-protein 4; E4 promoter-binding protein 4; E4BP4; Embryo implantation-related NFIL3/E4BP4-like transcription factor; IL3BP1; Interleukin-3 promoter transcriptional activator; interleukin-3-binding protein 1; NF IL3A; NFIL3; NFIL3A; NF-IL3A; nuclear factor interleukin 3 regulated protein; nuclear factor interleukin-3-regulated protein; nuclear factor, interleukin 3 regulated; nuclear factor, interleukin 3, regulated; OTTHUMP00000021633; transcriptional activator NF-IL3A | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
4783 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
Q16649 | |
NFIL3 | |
Recombinant protein encompassing a sequence within the center region of human NFIL3. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction